Panacos Pharmaceuticals, Inc.
PANC
$0.00
$0.000.00%
OTC PK
| 09/30/2008 | 06/30/2008 | 03/31/2008 | 12/31/2007 | 09/30/2007 | |
|---|---|---|---|---|---|
| Revenue | 24.00K | 18.00K | 35.00K | 22.00K | 30.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 24.00K | 18.00K | 35.00K | 22.00K | 30.00K |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 24.00K | 18.00K | 35.00K | 22.00K | 30.00K |
| SG&A Expenses | 2.22M | 2.57M | 3.16M | 3.06M | 3.23M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 7.60M | 9.24M | 8.22M | 9.28M | 8.22M |
| Operating Income | -7.57M | -9.22M | -8.18M | -9.26M | -8.19M |
| Income Before Tax | -8.15M | -9.74M | -8.51M | -9.35M | -7.91M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -8.15M | -9.74M | -8.51M | -9.35M | -7.91M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -8.15M | -9.74M | -8.51M | -9.35M | -7.91M |
| EBIT | -7.57M | -9.22M | -8.18M | -9.26M | -8.19M |
| EBITDA | -7.47M | -9.12M | -8.09M | -9.16M | -8.09M |
| EPS Basic | -0.15 | -0.18 | -0.16 | -0.17 | -0.15 |
| Normalized Basic EPS | -0.10 | -0.11 | -0.10 | -0.11 | -0.09 |
| EPS Diluted | -0.15 | -0.18 | -0.16 | -0.17 | -0.15 |
| Normalized Diluted EPS | -0.10 | -0.11 | -0.10 | -0.11 | -0.09 |
| Average Basic Shares Outstanding | 53.64M | 53.58M | 53.55M | 53.53M | 53.50M |
| Average Diluted Shares Outstanding | 53.64M | 53.58M | 53.55M | 53.53M | 53.50M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |